DJIA 18,040.37 29.69 0.16%
NASDAQ 5,082.93 12.90 0.25%
S&P 500 2,111.73 4.34 0.21%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)

company name or ticker

Pfizer's Monstrous Clinical Pipeline Is Harboring 2 Hidden Gems

Pfizer's mind-boggling size often results in promising clinical candidates getting swept under the rug, so to speak. Here is a look at two of the pharma giant's orphan drug candidates that haven't generated much talk among investors, despite being potential game-changers for their target indications.

3 Stocks That Could Double Your Money

Biotech has produced numerous stocks recently that have doubled or tripled in short periods of time. Here is a look at three small-cap companies with the potential to continue this trend.

Did BioMarin Bet on the Wrong Experimental DMD Drug?

Sarepta Therapeutics may hold a key advantage over BioMarin in the race to bring a game-changing Duchenne muscular dystrophy drug to market. Here's why.

Uh-Oh! Billionaire George Soros Just Stepped on Another Biotech Landmine

George Soros is one of the most closely watched figures in the investing world. Retail investors, though, shouldn't necessarily take cues from his hedge fund. Here's why.

Today's Dead Cat Bounce Stock Is Sarepta Therapeutics (SRPT)

Health Care Sector Update for 05/22/2015: SRPT, AMGN, MRK

BofA Downgrades Sarepta, But Hikes Price Target

Today's Perilous Reversal Stock: Sarepta Therapeutics (SRPT)

Bank of America Downgrades Sarepta Therapeutics To Neutral

Sarepta Therapeutics Inc (SRPT) Will File NDA; Analysts Have Mixed Ratings

See More Articles...